Saronic Biotechnology
NY - New YorkBiotechnology
Focus: Saronic Biotechnology is a specialized oncology-focused biotech company developing autologous dendritic cell immunotherapy for hepatocellular carcinoma, operating from New York headquarters.
Profile data last refreshed 2h ago · AI intelligence enriched 1mo ago
Open Jobs
277+288 this month
Hot — 300 jobs added in 30d
Net +288 (300 new, 12 removed). Aggressive expansion phase.
Should You Work at Saronic Biotechnology?
AI assessmentSaronic represents a high-risk, high-potential-impact early-stage play in cell immunotherapy, suitable only for scientists willing to bet on unproven science with minimal hiring activity.
Why Work Here
- Focused pipeline in high-unmet-need space: dendritic cell immunotherapy for HCC represents an emerging immunotherapy modality with limited competition
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Saronic Biotechnology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.